Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PYXANT LABS INC

NPI: 1386003598 · COLORADO SPRINGS, CO 80907 · Clinical Medical Laboratory · NPI assigned 02/16/2016

$1.19M
Total Medicaid Paid
83,545
Total Claims
55,361
Beneficiaries
44
Codes Billed
2018-01
First Month
2020-03
Last Month

Provider Details

Authorized OfficialGAUBATZ, MAURICE (OWNER CEO)
NPI Enumeration Date02/16/2016

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 21,378 $240K
2019 55,230 $838K
2020 6,937 $112K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,467 4,998 $89K
80373 5,471 3,341 $82K
80354 5,487 3,356 $82K
80372 5,388 3,285 $82K
80360 5,259 3,174 $79K
80357 4,355 2,304 $71K
80350 3,693 1,670 $60K
80324 3,639 1,766 $60K
80367 3,525 1,503 $57K
80323 2,917 1,609 $47K
80363 2,726 1,636 $43K
80371 2,577 1,161 $42K
80364 2,676 1,690 $39K
80346 2,103 1,921 $28K
80368 1,562 914 $25K
80361 1,884 1,737 $25K
80365 1,909 1,799 $24K
80349 1,467 915 $23K
80359 1,702 1,539 $20K
80348 1,514 1,311 $20K
80325 1,646 1,492 $20K
80377 1,078 505 $18K
80355 1,291 1,133 $17K
80356 1,373 1,295 $16K
80358 1,342 1,266 $15K
80353 1,028 953 $13K
80321 727 647 $12K
80332 695 409 $11K
80345 971 904 $11K
83992 890 838 $11K
80342 637 400 $10K
80370 647 616 $10K
80366 760 685 $9K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1,880 1,708 $6K
80369 296 272 $5K
80338 284 192 $4K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 401 206 $2K
80374 46 38 $726.11
80335 28 25 $480.79
80337 29 16 $37.17
80339 30 16 $37.17
80343 30 16 $37.17
80351 37 23 $10.61
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 78 77 $0.00